Rabies Pipeline Highlights – 2017 Update

1. Rabies Pipeline by Stages

2. Rabies Pipeline by Drug Class

3. Rabies Pipeline by Company

4. Rabies Phase 3 Clinical Trial Insights

5. Rabies Phase 2 Clinical Trial Insights

6. Rabies Phase 1 Clinical Trial Insights

7. Rabies Preclinical Research Insights

8. Rabies Discovery Stage Insights

9. Appendix

10. Research Methodology

LIST OF TABLES

Table 1: Rabies Phase 3 Clinical Trials, 2017

Table 2: Rabies Phase 2 Clinical Trials, 2017

Table 3: Rabies Phase 1 Clinical Trials, 2017

Table 4: Rabies Preclinical Research, 2017

Table 5: Rabies Discovery Stage, 2017

LIST OF FIGURES

Figure 1: Rabies Pipeline Molecules by Clinical Trials Stage, 2017

Figure 2: Rabies Pipeline Molecules by Drug Class, 2017

Figure 3: Rabies Pipeline Molecules by Company, 2017

Figure 4: Rabies Phase 3 Clinical Trial Highlights, 2017

Figure 5: Rabies Phase 2 Clinical Trial Highlights, 2017

Figure 6: Rabies Phase 1 Clinical Trial Highlights, 2017

Figure 7: Rabies Preclinical Research Highlights, 2017

Figure 8: Rabies Discovery Stage Highlights, 2017

Rabies Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Rabies Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Rabies market. It covers emerging therapies for Rabies in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Rabies pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Rabies pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Rabies pipeline products by the company.

Short-term Launch Highlights:
Find out which Rabies pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

• Rabies phase 3 clinical trial pipeline products
• Rabies phase 2 clinical trial pipeline products
• Rabies phase 1 clinical trial pipeline products
• Rabies preclinical research pipeline products
• Rabies discovery stage pipeline products
• Rabies pipeline products short-term launch highlights